Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

859.7000 -3.45 (-0.40%)

NSE Aug 14, 2025 15:31 PM

101.31% Gain from 52W Low

Volume: 2.9M

Laurus Labs Ltd.

05 Aug 2019

859.70

-0.40%

Laurus Labs (BUY): High opex offsets formulation positives; expect recovery in Q2

Buy: Laurus Labs Ltd.

BOB Capital Markets Ltd.

Q1FY20 operational results were in line despite strong gross margin expansion.

Laurus Labs Ltd. has an average target of 686.25 from 4 brokers.